Serum Eicosanoids Metabolomics Profile in a Mouse Model of Renal Cell Carcinoma: Predicting the Antitumor Efficacy of Anlotinib

Anlotinib (ANL) shows promising efficacy in patients with renal cell cancer (RCC). Here, for the first time, a serum eicosanoid metabolomics profile and pharmacodynamics in Renca syngeneic mice treated with ANL was performed and integrated using our previous HPLC-MS/MS method and multivariate statis...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Ping, Xuan, Lingling, Hu, Ting, An, Zhuoling, Liu, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863591/
https://www.ncbi.nlm.nih.gov/pubmed/35222406
http://dx.doi.org/10.3389/fimmu.2022.824607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863591/
https://www.ncbi.nlm.nih.gov/pubmed/35222406
http://dx.doi.org/10.3389/fimmu.2022.824607

Ejemplares similares